Echocardiography continues to be the noninvasive method of choice in t
he evaluation of valvular heart disease. Important recent developments
include clinical validation of approaches used to quantify valvular r
egurgitation, in particular the proximal flow convergence zone method;
use of transesophageal imaging to monitor and evaluate surgical or pe
rcutaneous interventions in valvular heart disease, in particular mitr
al valve repair; insight into flow-related stretch of the orifice area
in aortic stenosis; and validation of nuclear magnetic resonance imag
ing in small series for quantification of left-sided valvular stenotic
and regurgitant lesions.